We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How MHRA addresses the implications for pharmacists after the exemption from holding a wholesale dealer’s licence (WDA(H)) was revoked.
Advice for healthcare professionals on how to use blood glucose meters safely and effectively.
Guidance for hospital blood banks on issuing blood components electronically in line with best practice.
Guidance on providing patient information leaflets in formats suitable for blind and partially-sighted patients.
Update on MHRA UK risk-based GxP inspection programme.
Guidance for industry on preparing responses to good laboratory practice (GLP) and good clinical practice (GCP) inspection reports.
summary
How and when to register updated packaging and information leaflets when new national marketing authorisations have been issued
Guidance on sources of electromagnetic interference and mitigating the risks.
UK guidance on re-manufacturing of Single-use medical devices.
Actions that trial sponsors should consider to build resilience into clinical trial design
A summary of actions related to problems with T34 syringe drivers
Which submission type to select when submitting a notification of intent to market e-cigarette and vape products in Great Britain.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Our Patient Involvement Strategy sets out how we will engage and involve the public and patients at every step of the regulatory journey.
What is considered off-label use of a medical device and examples of it.
Guidance for industry on flexible approaches we are taking on good distribution practices.
Guidance on the cardiovascular safety of Cox-2 inhibitors and NSAIDs and further reading.
The MHRA has become increasingly aware of infrared thermometers being sold in the UK that do not comply with the regulations.
The EU has published guidance on exemptions for medical devices manufactured and used within EU health institutions, which applies to Northern Ireland-based health institutions, replacing interim guidance from the MHRA.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).